(14:06 GMT) Adaptive Biotechnologies Price Target Raised to $22.00/Share From $21.00 by Guggenheim
Dow Jones Newswires
Adaptive Biotechnologies Is Maintained at Buy by Guggenheim
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:ADPT
- Language
- English